Quantitative assessment of cerebral hemodynamics using perfusion-weighted MRI in patients with major cerebral artery occlusive disease: Comparison with positron emission tomography

Stroke

Volumn 37, Issue 2, 2006, Pages 388-392

  Endo, Hidehiko ^a   Inoue, Takashi ^a   Ogasawara, Kuniaki ^a   Fukuda, Takeshi ^a   Kanbara, Yoshiyuki ^a   Ogawa, Akira ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Cerebral blood volume; Magnetic resonance imaging; Perfusion weighted imaging

Indexed keywords

ACETAZOLAMIDE;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VOLUME; BRAIN BLOOD FLOW; CEREBRAL BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INDICATOR DILUTION CURVE; INTERMETHOD COMPARISON; IONIZING RADIATION; MALE; MIDDLE CEREBRAL ARTERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROVOCATION TEST; QUANTITATIVE ANALYSIS; REGION OF INTEREST; THREE DIMENSIONAL IMAGING; VALIDATION STUDY; VISUAL FIELD; BRAIN; BRAIN ARTERY; BRAIN CIRCULATION; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; HEMODYNAMICS; MAGNETIC RESONANCE ANGIOGRAPHY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RECURRENT DISEASE; RISK; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME; VASCULARIZATION;

ADULT; AGED; ARTERIAL OCCLUSIVE DISEASES; BRAIN; CEREBRAL ARTERIES; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE; RISK; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 33644862718     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000199030.37274.88     Document Type: Article

References (26)

1. Gibbs JM, Wise RJ, Leenders KL, Jones T. Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet. 1984;1:310-314.
2. Powers WJ, Raichle ME. Positron emission tomography and its application to the study of cerebrovascular disease in man. Stroke. 1985;16:361-376.
3. Ringelstein EB, Grosse W, Matentzoglu S, Glockner WM. Non-invasive assessment of the cerebral vasomotor reactivity by means of transcranial doppler sonography during hyper- and hypocapnea. Klin Wochenschr. 1986;64:194-195.
4. Ringelstein EB, Van Eyck S, Mertens I. Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: comparison of CO2 to acetazolamide. J Cereb Blood Flow Metab. 1992;12:162-168.
5. Nemoto EM, Yonas H, Kuwabara H, Pindzola RR, Sashin D, Meltzer CC, Price JC, Chang Y, Johnson DW. Identification of hemodynamic compromise by cerebrovascular reserve and oxygen extraction fraction in occlusive vascular disease. J Cereb Blood Flow Metab. 2004;24:1081-1089.
6. Yamauchi H, Okazawa H, Kishibe Y, Sugimoto K, Takahashi M. Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease. J Neurol Neurosurg Psychiatry. 2004;75:33-37.
7. Apruzzese A, Silvestrini M, Floris R, Vernieri F, Bozzao A, Hagberg G, Caltagirone C, Masala S, Simonetti G. Cerebral hemodynamics in asymptomatic patients with internal carotid artery occlusion: a dynamic susceptibility contrast MR and transcranial doppler study. AJNR Am J Neuroradiol. 2001;22:1062-1067.
8. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med. 1996;36:726-736.
9. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med. 1996;36:715-725.
10. Lin W, Celik A, Derdeyn C, An H, Lee Y, Videen T, Ostergaard L, Powers WJ. Quantitative measurements of cerebral blood flow in patients with unilateral carotid artery occlusion: a PET and MR study. J Magn Reson Imaging. 2001;14:659-667.
11. Ostergaard L, Johannsen P, Host-Poulsen P, Vestergaard-Poulsen P, Asboe H, Gee AD, Hansen SB, Cold GE, Gjedde A, Gyldensted C. Cerebral blood flow measurements by magnetic resonance imaging bolus tracking: comparison with [(15)o]h2o positron emission tomography in humans. J Cereb Blood Flow Metab. 1998;18:935-940.
12. Ostergaard L, Smith DF, Vestergaard-Poulsen P, Hansen SB, Gee AD, Gjedde A, Gyldensted C. Absolute cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking: comparison with positron emission tomography values. J Cereb Blood Flow Metab. 1998;18:425-432.
13. Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology. 1994;193:637-641.
14. Smith AM, Grandin CB, Duprez T, Mataigne F, Cosnard G. Whole brain quantitative CBF, CBV, and MTT measurements using MRI bolus tracking: implementation and application to data acquired from hyperacute stroke patients. J Magn Reson Imaging. 2000;12:400-410.
15. Ogasawara K, Ito H, Sasoh M, Okuguchi T, Kobayashi M, Yukawa H, Terasaki K, Ogawa A. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123i-n-isopropyl-p-iodoamphetamine autoradiography with spect: validation study using h2 15o with PET. J Nucl Med. 2003;44:520-525.
16. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke. 2001;32:2110-2116.
17. Ogasawara K, Ogawa A, Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke. 2002;33:1857-1862.
18. Yonas H, Smith HA, Durham SR, Pentheny SL, Johnson DW. Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg. 1993;79:483-489.
19. Ogasawara K, Yukawa H, Kobayashi M, Mikami C, Konno H, Terasaki K, Inoue T, Ogawa A. Prediction and monitoring of cerebral hyperperfusion after carotid endarterectomy by using single-photon emission computerized tomography scanning. J Neurosurg. 2003;99:504-510.
20. Kikuchi K, Murase K, Miki H, Kikuchi T, Sugawara Y, Mochizuki T, Ikezoe J, Ohue S. Measurement of cerebral hemodynamics with perfusion-weighted MR imaging: Comparison with pre- and post-acetazolamide 133xe-spect in occlusive carotid disease. AJNR Am J Neuroradiol. 2001;22:248-254.
21. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med. 1995;34:555-566.
22. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med. 1994;31:601-610.
23. Lythgoe DJ, Ostergaard L, William SC, Cluckie A, Buxton-Thomas M, Simmons A, Markus HS. Quantitative perfusion imaging in carotid artery stenosis using dynamic susceptibility contrast-enhanced magnetic resonance imaging. Magn Reson Imaging. 2000;18:1-11.
24. Reinhard M, Muller T, Roth M, Guschlbauer B, Timmer J, Hetzel A. Bilateral severe carotid artery stenosis or occlusion - cerebral autoregulation dynamics and collateral flow patterns. Acta Neurochir (Wien). 2003;145:1053-1059;discussion 1059-1060.
25. Grandin CB, Bol A, Smith AM, Michel C, Cosnard G. Absolute CBF and CBV measurements by MRI bolus tracking before and after acetazolamide challenge: repeatabilily and comparison with PET in humans. Neuroimage. 2005;26:525-535.
26. Derdeyn CP, Videen TO, Yundt KD, Fritsch SM, Carpenter DA, Grubb RL, Powers WJ. Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. Brain. 2002;125:595-607.